Tag Archives: Fatal
Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings
Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.
Sudden Death in Those Taking Bactrim Along with ACE Inhibitors or ARBs
Association between sudden death in those given Bactrim while already taking renin-angiotensin system blockers angiotensin receptor blockers (ARBs), heart medications.
Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions
Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...
Former Executives Accuse Health Technology Firm of Fraud
Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.
Lawsuit Alleges Bi-Lateral DePuy ASR Hip Implant Resulted in Elevated Chromium and Cobalt Levels, Need for Revision Surgery
DePuy Orthopaedics and its parent, Johnson & Johnson, continue to be named in lawsuits by metal-on-metal hip replacement recipients who suffered severe injuries, including elevated chromium and cobalt levels, allegedly due to recalled ASR hip implant devices. Most recently, the national law firm of Parker Waichman LLP filed suit on ...
DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy
The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.
Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit
A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...
Three Injured When Long Island Railroad Train Hits Car on Tracks
3 people, injured on Wednesday at 1:20 p.m. when a LIRR train hit a livery cab on the tracks west of Wyandanch station. The train engineer, who suffered a shoulder injury.
Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation
A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.Class I Recall Issued for Brainlab Cranial IGS System
The U.S. Food and Drug Administration (FDA) has puts its most serious Class I label on a recall of Brainlab’s Image-Guided Surgery (IGS) System. According to an FDA recall notification, the system was recalled due to potential inaccuracy. Class I … Continue reading
Study Finds Elevated Risk of Leukemia with Long-Term Low-Dose Radiation
High doses of ionizing radiation, such as that released by atomic bombs, are a known cause of leukemia. A new long-term study published in The Lancet Haematology has looked at the rates of leukemia with low-doses of radiation long-term. Researchers … Continue reading
Pedestrian Killed after being Hit by Car in Bayshore
A woman walking across 5th avenue in Bay Shore was fatally struck by a car Tuesday night. Newsday reports that the 66-year-old victim was hit by a 2000 Nissan Maxima headed southbound at 8:47 p.m. A physician assistant from the … Continue reading
Woman Dies After Taking Diet Pill Tainted with DNP
The tragic death of a 21-year-old college student in the U.K. highlights the dangers of buying quick-fix weight loss products online.
Continue reading
FDA Says Diabetes Drug Onglyza May be Linked to Higher Death Rate
After conducting a preliminary review of data, the U.S. Food and Drug Administration (FDA) has issued a report indicating that AstraZeneca’s diabetes drug Onglyza may be linked with an increased rate of death. According to Reuters, an FDA advisory panel … Continue reading
FDA Slow to Warn About Dietary Supplement Dangers
A newly published study is critical of the Food and Drug Administration (FDA) for being slow to take action against weight-loss and dietary supplements that contain chemical ingredients that pose health risks to supplement takers. Though the FDA determined two … Continue reading
Middle-aged Dronedarone Users Have Higher Risk of Hospitalization
New study results reveal that patients age 61 and younger treated with the heart rhythm drug dronedarone (Multaq) have a higher risk for hospitalization than those with treated other anti-arrhythmic drugs. The study, published in Circulation: Cardiovascular Quality and Outcomes, … Continue reading
Will FDA Ban Powdered Caffeine?
The U.S. Food and Drug Administration (FDA) has seldom used its authority to ban supplements from the market, but some regulatory experts say the agency should implement that power for powdered caffeine, which has been linked to at least two … Continue reading
FDA Strengthens Warning Label on Feraheme
The U.S. Food and Drug Administration (FDA) is strengthening an existing warning on the anemia drug Feraheme (ferumoxytol) to reduce the risk of serious, potentially fatal allergic reactions. According to an FDA Safety Announcement dated March 30th, the agency has … Continue reading
Food and Drug Administration Issues Response to Petition for Removal of Essure Birth Control from Market
Last week the Food and Drug Administration (FDA) responded to a petition demanding removal of Essure permanent birth control device from the market. The petition was signed by more than 2,100 women who are concerned about injuries and adverse effects … Continue reading
